Prenetics names Brian Rosin as successor CFO to Stephen Lo

Prenetics Global Limited announced on November 3, 2026 that Brian J. Rosin will succeed Stephen Lo as Chief Financial Officer of Prenetics, effective December 31, 2026.¹ The company's Board of Directors is expected to formalize the appointment at its meeting on November 12, 2026.¹

Rosin joined IM8, Prenetics' flagship brand, as its CFO in May 2026. He will serve as Chief Financial Officer-designate of Prenetics through year-end while continuing as CFO of IM8 alongside Lo, before taking over leadership of the company's global finance organization and reporting to CEO Danny Yeung.¹ Because IM8 now represents substantially all of Prenetics' revenue, the company will operate with a single CFO, and the separate IM8 CFO role will not be refilled.¹

Since joining, Rosin has co-led the company's quarterly earnings presentations, helped arrange a $1 billion growth commitment financing from General Catalyst's Customer Value Fund, and worked to expand the company's contact with U.S. investors and sell-side analysts, according to the company.¹

Lo, who has served as CFO, will remain through December 30, 2026 to support the handover, and will then stay on with the company as a Senior Advisor.¹

As part of a broader move of finance staff to the U.S., Cindy Tat joined the company in August 2026 as Vice President, Financial Controller; she is a U.S.-based CPA with more than 16 years of SEC reporting and SOX compliance experience, having previously served as Vice President, Controller at Nasdaq-listed WM Technology and at Iteris.¹

Separately, Prenetics said it will report third quarter 2026 financial results on Wednesday, November 18, 2026, and will hold a live-stream earnings event on Stocktwits at 8:30 a.m. Eastern Time, following the same format used for its second quarter event.¹ Yeung and Rosin will review the results and take questions.¹